selection

pharmaceutical industry

This tag is associated with 3 posts

European Parliament Plenary Session – April II 2019

Unsurprisingly, the agenda for this final plenary session of Parliament’s 2014-2019 term will deal with a range of issues that are emblematic of the major themes that have marked this eighth legislature. Continue reading

Therapies for the future – Advanced therapies & nanomedicine

Advanced therapy medicinal products constitute a heterogeneous group of biopharmaceuticals encompassing gene therapy and somatic cell therapy medicinal products, as well as tissue-engineered and combined products (tissues or cells associated with a device). Continue reading

Therapies for the future – Exploring the potential of innovative treatments in Europe

The purpose of this workshop is to report on the status of nanomaterial-based and advanced therapy medicinal products, as well as on possible pathways for the future development of these new therapies in Europe. Continue reading

Download the EPRS App

EPRS App on Google Play
EPRS App on App Store
What Europe Does For You
EU Legislation in Progress
Topical Digests
EPRS Podcasts

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 2,974 other followers

Disclaimer and Copyright statement

The content of all documents (and articles) contained in this blog is the sole responsibility of the author and any opinions expressed therein do not necessarily represent the official position of the European Parliament. It is addressed to the Members and staff of the EP for their parliamentary work. Reproduction and translation for non-commercial purposes are authorised, provided the source is acknowledged and the European Parliament is given prior notice and sent a copy.

For a comprehensive description of our cookie and data protection policies, please visit Terms and Conditions page.

Copyright © European Union, 2014-2019. All rights reserved.